Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]
Home »

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

Mar 09, 2024

ABOUT THE EXPERTS

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RELEVANT ARTICLES FOR YOU

Advertisement
[adinserter block="6" template="Article Pages" check="exceptions" ignore="page-type"]